Abstract
While cancers in children and adolescents are overall rare, some cancer types occur predominantly in children and adolescents. Typical pediatric cancers share characteristics like few genetic alterations and disturbed cell differentiation, and occur more often in children with inherited syndromes. Retinoblastoma exemplifies these characteristics. Almost all cases are caused by biallelic RB1 inactivation, followed by variable “third event” mutations. Wilms tumors are genetically more heterogeneous. These nephroblastomas arise from regions of the develo** kidney that have failed to complete differentiation. Some Wilms tumors are caused by germline or somatic mutations in WT1, but the disease can also be caused by mutations in genes encoding other transcription factors, chromatin regulators, and miRNA-processing proteins required for nephrogenesis. The WT1 transcription factor is involved in the development and differentiation of the genitourinary tract. Wilms tumors contain moreover epigenetic alterations in the chromosome 11p15.5 imprinted region. Testicular germ cell tumors (TGCT) typically manifest in young men. They are classified into seminomas and non-seminomas. Seminoma cells resemble primordial germ cells whereas the characteristic cells of non-seminomas, embryonal carcinoma cells, rather resemble embryonic stem cells and may further differentiate into various embryonic, extra-embryonic, and somatic cell types. Almost all TGCT can now be successfully treated by surgery and chemotherapy. TCGT appear to be caused predominantly by copy number changes, affecting especially chromosome 12p and by epigenetic alterations. In seminomas, point mutations in the KIT tyrosine kinase contribute. DNA methylation and miRNA expression patterns in TCGT are distinctive and can be exploited for diagnostics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Note that BCL6 is a potential tumor suppressor in retinoblastoma, but can act as an oncogene in B cell lymphomas.
- 2.
OCT4 immunohistochemical staining is an excellent biomarker to identify TGCT cells in histopathological diagnostics.
Further Reading
Ackermann S et al (2018) A mechanistic classification of clinical phenotypes in neuroblastoma. Science 362:1165–1170
Coorens THH et al (2019) Embryonal precursors of Wilms tumor. Science 366:1247–1251
Creff J, Besson A (2020) Functional versatility of the CDK inhibitor p57Kip2. Front Cell Dev Biol 8:584590
Davidoff AD (2009) Wilms’ tumor. Curr Opin Pediatr 21:357–364
De Toni L et al (2019) Testicular cancer: genes, environment, hormones. Front Endocrin 10:408
de Vries G et al (2020) Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities. Cancer Treat Rev 88:102054
Dieckmann KP et al (2012) MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumors. Brit J Cancer 107:1754–1760
Francis JH et al (2021) Molecular changes in retinoblastoma beyond RB1: findings from next-generation sequencing. Genes 13:149
Hanna NH, Einhorn LH (2014) Testicular cancer—discoveries and updates. NEJM 371:2005–2016
Hastie ND (2017) Wilms‘ tumour 1 (WT1) in development, homeostasis and disease. Development 144:2862–2872
Hovestadt V et al (2020) Medulloblastoma revisited: biological and clinical insights from thousands of patients. Nat Rev Cancer 20:42–56
King J et al (2021) Testicular cancer: biology to bedside. Cancer Res 81:5369–5376
Laetsch TW et al (2021) Opportunities and challenges in drug development for pediatric cancers. Cancer Disc 11:545–559
Lee SB, Haber DA (2001) Wilms tumor and the WT1 gene. Exp Cell Res 264:74–99
Li H et al (2021) Embryonic kidney development, stem cells and the origin of Wilms tumor. Genes 12:318
Martinez-Sanchez M et al (2022) Retinoblastoma: from discovery to clinical management. FEBS J 289:4371–4382
Menke AL, Schedl A (2003) WT1 and glomerular function. Semin Cell Dev Biol 14:233–240
Newman S et al (2021) Genomes for kids: the scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing. Cancer Disc 11:3008–3027
Rijlaarsdam MA et al (2015) Genome wide DNA methylation profiles provide clues to the origin and pathogenesis of germ cell tumors. PLoS ONE 10:e0122146
Shah MM et al (2004) Branching morphogenesis and kidney disease. Development 131:1449–1462
Shen H et al (2018) Integrated molecular characterization of testicular germ cell tumors. Cell Rep 23:3392–3406
Sweet-Cordero EA, Biegel JA (2019) The genomic landscape of pediatric cancers: implications for diagnosis and treatment. Science 363:1170–1175
Tang WWC et al (2016) Specification and epigenetic programming of the human germ line. Nat Rev Genet 17:585–600
Taylor-Weiner A et al (2016) Genomic evolution and chemoresistance in germ-cell tumours. Nature 540:114–118
Thériault BL et al (2014) The genomic landscape of retinoblastoma: a review. Clin Exp Opthamol 42:33–52
Treger TD et al (2019) The genetic changes of Wilms tumour. Nat Rev Nephrol 15:240–251
Ulbright TM et al (2016) Germ cell tumors. In: Moch H et al (eds) WHO classification of tumours of the urinary system and male genital organs, 4th edn. IARC, Lyon, pp 189–226
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Schulz, W.A. (2023). Pediatric Cancers. In: Molecular Biology of Human Cancers. Springer, Cham. https://doi.org/10.1007/978-3-031-16286-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-031-16286-2_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-16285-5
Online ISBN: 978-3-031-16286-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)